Clinical Trial: A Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec

U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07632404) titled 'A Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec' on June 02.

Brief Summary: The study will look at how well insulin icodec controls blood sugar levels in participants who have never used it before. Participants with type 2 diabetes (T2D) will be treated with insulin icodec as prescribed to by their doctor, in accordance with usual clinical practice. This study will last for about 22 to 30 weeks.

Study Start Date: June 05

Study Type: OBSERVATIONAL

Condition: Diabetes Mellitus, Type 2

Interven...